country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

製品番号: HY-106685

Copy Link Print Information

Selenazofurin

Name: Selenazofurin
Brand: MedChemExpress
SKU: HY-106685
Availability: PreOrder

(別名: CI 935)

Selenazofurin is an antiviral compound used against influenza A and influenza B viruses. Selenazofurin shows antiviral activity in cells against Measles, Para-3, Mumps, VV, HSV-2 with the ED₅₀s of 3.7 μg/ml, 1.3 μg/ml, 8.0 μg/ml, 3.4 μg/ml, 4.3 μg/ml.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

CAS 番号: 83705-13-9
分子式: C₉H₁₂N₂O₅Se
分子量:307.16

保管条件:

Please store the product under the recommended conditions in the Certificate of Analysis.

Selenazofurin 構造式

CAS 番号: 83705-13-9

容量

価格（税別）

在庫状況

数量

Amount: USD 0.00

* アイテムを追加する前、数量をご選択ください

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

生物活性

製品説明

Cellular Effect

Cell Line	Type	Value	Description	References
5637	IC₅₀	2.3 μM Compound: Selenazofurin	Compound was tested for antiproliferative activity against 5637, human bladder carcinoma cell line Compound was tested for antiproliferative activity against 5637, human bladder carcinoma cell line	[PMID: 9171883]
ACHN	IC₅₀	13.8 μM Compound: Selenazofurin	Compound was tested for antiproliferative activity against ACHN, human renal adenocarcinoma Compound was tested for antiproliferative activity against ACHN, human renal adenocarcinoma	[PMID: 9171883]
CCRF-CEM	IC₅₀	1.2 μM Compound: Selenazofurin	Compound was tested for antiproliferative activity against CCRF-CEM, human acute T-lymphoblastic leukemia Compound was tested for antiproliferative activity against CCRF-CEM, human acute T-lymphoblastic leukemia	[PMID: 9171883]
CCRF-SB	IC₅₀	1.5 μM Compound: Selenazofurin	Compound was tested for antiproliferative activity against CCRF-SB, human acute B-lymphoblastic leukemia Compound was tested for antiproliferative activity against CCRF-SB, human acute B-lymphoblastic leukemia	[PMID: 9171883]
CHO-K1	IC₅₀	0.6 μM Compound: Selenazofurin	Compound was tested for antiproliferative activity against CHO-K1, Chinese hamster ovary Compound was tested for antiproliferative activity against CHO-K1, Chinese hamster ovary	[PMID: 9171883]
HeLa	IC₅₀	7.9 μM Compound: Selenazofurin	Compound was tested for antiproliferative activity against HeLa, human cervix carcinoma Compound was tested for antiproliferative activity against HeLa, human cervix carcinoma	[PMID: 9171883]
HT-29	IC₅₀	7.7 μM Compound: Selenazofurin	Compound was tested for antiproliferative activity against HT29, human colon adenocarcinoma Compound was tested for antiproliferative activity against HT29, human colon adenocarcinoma	[PMID: 9171883]
K562	IC₅₀	0.5 μM Compound: Selenazofurin	Compound was tested for antiproliferative activity against K562, human erythroid leukemia Compound was tested for antiproliferative activity against K562, human erythroid leukemia	[PMID: 9171883]
L1210	IC₅₀	0.5 μM Compound: Selenazofurin	Compound was tested for antiproliferative activity against L1210, murine lymphocytic leukemia Compound was tested for antiproliferative activity against L1210, murine lymphocytic leukemia	[PMID: 9171883]
MOLT-4	IC₅₀	0.6 μM Compound: Selenazofurin	Compound was tested for antiproliferative activity against MOLT-4, human acute T-lymphoblastic leukemia Compound was tested for antiproliferative activity against MOLT-4, human acute T-lymphoblastic leukemia	[PMID: 9171883]
Raji	IC₅₀	1.6 μM Compound: Selenazofurin	Compound was tested for antiproliferative activity against Raji, human Burkitt lymphoma Compound was tested for antiproliferative activity against Raji, human Burkitt lymphoma	[PMID: 9171883]
Vero	ED₅₀	1.4 x 10^-5M Compound: Selenazofurin	In vitro antiviral activity against herpes simplex virus type 2 virus was evaluated. In vitro antiviral activity against herpes simplex virus type 2 virus was evaluated.	[PMID: 4020823]
Vero	ED₅₀	3.2 x 10^-6M Compound: Selenazofurin	In vitro antiviral activity against measles virus was evaluated. In vitro antiviral activity against measles virus was evaluated.	[PMID: 4020823]
Vero	ED₅₀	3.2 x 10^-6M Compound: Selenazofurin	In vitro antiviral activity against Parainfluenza type 3 was evaluated. In vitro antiviral activity against Parainfluenza type 3 was evaluated.	[PMID: 4020823]
Vero	ED₅₀	9.8 x 10^-6M Compound: Selenazofurin	In vitro antiviral activity against vaccinia virus was evaluated. In vitro antiviral activity against vaccinia virus was evaluated.	[PMID: 4020823]
WIL2-NS	IC₅₀	1.2 μM Compound: Selenazofurin	Compound was tested for antiproliferative activity against Wil2-NS, human splenic lymphoblastoid cells Compound was tested for antiproliferative activity against Wil2-NS, human splenic lymphoblastoid cells	[PMID: 9171883]

化学情報

CAS 番号 83705-13-9
分子量 307.16
分子式 C₉H₁₂N₂O₅Se
SMILES

O[C@H]1[C@@H](O)[C@H](C2=NC(C(N)=O)=C[Se]2)O[C@@H]1CO
別名

CI 935
輸送条件

Room temperature in continental US; may vary elsewhere.
保管条件

Please store the product under the recommended conditions in the Certificate of Analysis.

純度とドキュメンテーション

取扱説明書 (2659 KB)

参考文献

[1]. J J Kirsi, et al. Broad-spectrum synergistic antiviral activity of selenazofurin and ribavirin. Antimicrob Agents Chemother. 1984 Oct;26(4):466-75. [Content Brief]

Calculators

モル濃度計算機

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

濃度濃度

体積体積

分子量分子量

希釈計算機

濃度 _(開始) × 体積 _(開始) = 濃度 _(終了) × 体積 _(終了)

濃度 _(開始) 濃度 _(開始)

体積 _(開始) 体積 _(開始)

濃度 _(終了) 濃度 _(終了)

体積 _(終了) 体積 _(終了)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

お問い合わせ在庫あり

Other size

お問い合わせ